We are live on ! Find out more
MNG

Manning & Napier Group Portfolio holdings

AUM $8.76B
1-Year Est. Return 23.27%
This Fund
S&P 500
This Quarter Est. Return
+4.6%
1 Year Est. Return
+23.27%
3 Year Est. Return
+31.12%
5 Year Est. Return
+100.85%
10 Year Est. Return
AUM
$10.1B
AUM Growth
-$45.2M
Cap. Flow
-$367M
Cap. Flow %
-3.62%
Top 10 Hldgs %
27.26%
Holding
367
New
43
Increased
103
Reduced
136
Closed
40

Top Sells

1
DVA icon
DaVita
DVA
+$124M
2
WY icon
Weyerhaeuser
WY
+$114M
3
MDT icon
Medtronic
MDT
+$90.8M
4
QRVO icon
Qorvo
QRVO
+$89.1M
5
EEFT icon
Euronet Worldwide
EEFT
+$87.4M

Sector Composition

1 Healthcare 23.14%
2 Consumer Discretionary 14.09%
3 Technology 12.6%
4 Financials 9.6%
5 Consumer Staples 8.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
META icon
1
Meta Platforms (Facebook)
META
$1.63T
$378M 3.72%
1,944,105
+603,199
+45% +$109M
MDT icon
2
Medtronic
MDT
$108B
$308M 3.04%
3,597,837
-1,087,108
-23% -$90.8M
INCY icon
3
Incyte
INCY
$23.9B
$287M 2.83%
4,284,594
+2,409,374
+128% +$165M
BKNG icon
4
Booking.com
BKNG
$141B
$281M 2.77%
3,465,150
-228,275
-6% -$19.2M
UL icon
5
Unilever
UL
$137B
$280M 2.76%
4,508,708
-416,632
-8% -$25.9M
NVS icon
6
Novartis
NVS
$296B
$278M 2.74%
4,109,151
-82,169
-2% -$5.67M
SLB icon
7
SLB Ltd
SLB
$70B
$252M 2.48%
3,754,237
-296,085
-7% -$20.3M
LULU icon
8
lululemon athletica
LULU
$13.4B
$240M 2.37%
1,923,994
-622,042
-24% -$66.3M
QRVO icon
9
Qorvo
QRVO
$7.38B
$233M 2.29%
2,901,437
-1,152,795
-28% -$89.1M
MA icon
10
Mastercard
MA
$485B
$228M 2.25%
1,161,785
-12,460
-1% -$2.34M
MSFT icon
11
Microsoft
MSFT
$2.93T
$211M 2.08%
2,141,898
-76,925
-3% -$7.46M
V icon
12
Visa
V
$688B
$211M 2.08%
1,589,521
-109,288
-6% -$14.1M
BABA icon
13
Alibaba
BABA
$276B
$198M 1.95%
1,065,713
-101,347
-9% -$19.3M
JNJ icon
14
Johnson & Johnson
JNJ
$612B
$196M 1.94%
1,618,345
-7,141
-0.4% -$891K
NOW icon
15
ServiceNow
NOW
$107B
$188M 1.86%
5,457,140
-411,015
-7% -$14.2M
REGN icon
16
Regeneron Pharmaceuticals
REGN
$72.3B
$178M 1.76%
516,338
+23,315
+5% +$7.29M
BMRN icon
17
BioMarin Pharmaceuticals
BMRN
$11.6B
$177M 1.75%
1,883,673
-32,785
-2% -$2.87M
SCHW
18
Charles Schwab
SCHW
$178B
$158M 1.56%
3,101,140
+957,925
+45% +$53.1M
ABEV icon
19
Ambev
ABEV
$47B
$158M 1.56%
34,102,776
+492,401
+1% +$2.89M
BLK icon
20
Blackrock
BLK
$169B
$157M 1.55%
314,495
+79,865
+34% +$42.2M
SWKS icon
21
Skyworks Solutions
SWKS
$8.63B
$140M 1.38%
1,451,579
+28,220
+2% +$2.74M
ZAYO
22
DELISTED
Zayo Group Holdings, Inc.
ZAYO
$140M 1.38%
3,843,387
-109,245
-3% -$3.89M
EA icon
23
Electronic Arts
EA
$52.4B
$140M 1.38%
991,539
-306,754
-24% -$39.8M
BALL icon
24
Ball Corp
BALL
$17B
$139M 1.37%
3,911,925
-32,750
-0.8% -$1.25M
CF icon
25
CF Industries
CF
$18.6B
$131M 1.3%
2,961,421
+2,591,386
+700% +$106M

Similar funds

Manning & Napier Group's Q2 2018 Portfolio in Review

As of Q2 2018, Manning & Napier Group held 367 positions worth $10.1B, down 0.44% from $10.2B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Manning & Napier Group withdrew a net $367M in Q2 2018, closing 40 positions and reducing 136 holdings. Its most notable exit was Euronet Worldwide, an estimated $87.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 25% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Manning & Napier Group opened a new position in Altria Group worth $23M.

  • Manning & Napier Group's largest Q2 2018 buy was Altria Group: 405,855 shares worth $23M.
  • Manning & Napier Group added most to Incyte in Q2 2018, an estimated $165M increase.
  • Manning & Napier Group's biggest Q2 2018 reduction was DaVita, cutting an estimated $124M.
  • Manning & Napier Group fully exited Euronet Worldwide in Q2 2018, selling an estimated $87.4M.
  • Manning & Napier Group's ten largest holdings make up 27% of its $10.1B portfolio in Q2 2018.
  • Manning & Napier Group opened 43 new positions and closed 40 in Q2 2018.
  • Manning & Napier Group's portfolio value fell 0.44% quarter-over-quarter to $10.1B.

Based on Manning & Napier Group's 13F filing for Q2 2018, filed 13 Jul 2018.